BioSpace News Archive

Business

TRACON Pharmaceuticals Announces Appointment of Brian Daniels, M.D., to Scientific Advisory Board

Dr. Daniels was Senior Vice President at Bristol-Myers Squibb until 2014.

December 5, 2017

·

2 min read

Business

Peregrine Pharmaceuticals to Report Financial Results for Second Quarter of Fiscal Year 2018 After Market Close on December 11, 2017

Peregrine’s senior management will discuss financial results for the second quarter and review recent corporate developments.

December 5, 2017

·

2 min read

Business

Under the new agreements, KeraFast, Emulate, MetaStat, Gingko Bioworks, Orig3n and InviCRO have entered into or extended their leases and collectively growing their footprint by more than 120,000 square feet of research and development space throughout the building, which is now over 94 percent leased.

December 5, 2017

·

3 min read

Business

Opiant Pharmaceuticals Reports Fiscal First Quarter 2018 Financial Results

For the quarter ended October 31, 2017, Opiant generated revenue of approximately $22,000, compared to approximately $1.1 million in the quarter ended October 31, 2016. T

December 5, 2017

·

5 min read

New Webinar From METTLER TOLEDO Shares How Weighing Accuracy Can be Protected

External factors that can influence weighing accuracy are often overlooked, even though an unreliable weighing result can have a profound effect downstream on the quality of the final result.

December 5, 2017

·

2 min read

Pharm Country

Celgene Launches Celgene Cancer Care Links to Support Cancer Healthcare Capacity Building in Resource-Constrained Countries

Celgene Corporation today announced the launch of Celgene Cancer Care Links, a new grant program designed to support cancer healthcare capacity building in resource-constrained countries around the world.

December 5, 2017

·

4 min read

Bio NC

Magstim Introduces Advances in Technology for Treatment of Major Depressive Disorder

HORIZON TMS Therapy is a proven, safe and cost-effective treatment for MDD.

December 5, 2017

·

3 min read

Drug Development

Breakthrough Evidence on Vomaris Bioelectric Technology’s Impact on Wound Biofilm Infection

Vomaris announced today breakthrough results of the first controlled, preclinical in vivo evidence on the anti-biofilm impact of the Company’s bioelectric antimicrobial technology.

December 5, 2017

·

5 min read

Business

PMV Pharma Appoints Winston Kung as COO &CFO

Mr. Kung will help manage the development of PMV Pharma’s mutant p53 restoration drug pipeline, which got a boost this past February when the company completed a $74M series B financing round.

December 5, 2017

·

3 min read

Deals

Europe’s NeuroSearch Exploring Sale, Possible Liquidation of Company in the Next Few Months

The Board of Directors also stated that it would endeavour to have a final clarification of the Company’s future by the end of 2017.

December 5, 2017

·

2 min read